NYSE:CLNYColony Capital Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Colony Capital Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $2.69 +0.10 (+3.86 %) (As of 08/14/2020 04:00 PM ET) Add Compare Share Today's Range$2.59Now: $2.69▼$2.7150-Day Range$1.80MA: $2.19▼$2.6452-Week Range$1.33Now: $2.69▼$6.14Volume8.91 million shsAverage Volume6.19 million shsMarket Capitalization$1.30 billionP/E RatioN/ADividend YieldN/ABeta1.75 ProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media Colony Capital, Inc. (NYSE: CLNY) is a leading global investment management firm with assets under management of $43 billion. The Company manages capital on behalf of its stockholders, as well as institutional and retail investors in private funds, non-traded and traded real estate investment trusts and registered investment companies. The Company has significant holdings in: (a) the healthcare, industrial and hospitality property sectors; (b) Colony Credit Real Estate, Inc. (NYSE: CLNC) and NorthStar Realty Europe Corp. (NYSE: NRE), which are both externally managed by subsidiaries of the Company; and (c) various other equity and debt investments. The Company is headquartered in Los Angeles with key offices in New York, Paris and London, and has over 400 employees across 17 locations in ten countries.Read More Beat the Market (BTM) Rank™ 3.5 Analyst's Opinion Consensus RatingColony Capital has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $4.00, Colony Capital has a potential upside of 48.7% from its current price of $2.69.Amount of Analyst CoverageColony Capital has only been the subject of 1 research reports in the past 90 days. Previous Next 2.5 Community Rank Outperform VotesColony Capital has received 385 “outperform” votes. (Add your “outperform” vote.)Underperform VotesColony Capital has received 389 “underperform” votes. (Add your “underperform” vote.)Community SentimentColony Capital has received 50.26% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Colony Capital and other stocks. Vote “Outperform” if you believe CLNY will outperform the S&P 500 over the long term. Vote “Underperform” if you believe CLNY will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldColony Capital does not currently pay a dividend.Dividend GrowthColony Capital does not have a long track record of dividend growth. Previous Next 4.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Colony Capital insiders have bought more of their company's stock than they have sold. Specifically, they have bought $512,350.00 in company stock and sold $0.00 in company stock.Percentage Held by InsidersOnly 6.82% of the stock of Colony Capital is held by insiders.Percentage Held by Institutions77.53% of the stock of Colony Capital is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Colony Capital are expected to grow in the coming year, from ($0.07) to $0.19 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Colony Capital is -0.43, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Colony Capital is -0.43, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioColony Capital has a P/B Ratio of 0.17. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 3.5Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 4.0Valuation: 1.3 5 -4 -3 -2 -1 -Overall Beat the Market Rank™2.25 out of 5 stars Industry, Sector and Symbol Stock Exchange NYSE Industry Real estate investment trusts Sub-IndustryMortgage REITs SectorFinance Current SymbolNYSE:CLNY Previous Symbol CUSIP19624R10 CIK1467076 Webwww.clny.com Phone310-282-8820Debt Debt-to-Equity Ratio1.28 Current Ratio3.72 Quick Ratio3.72Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$2.33 billion Price / Sales0.56 Cash FlowN/A Price / Cash FlowN/A Book Value$16.25 per share Price / Book0.17Profitability EPS (Most Recent Fiscal Year)$0.50 Net Income$-1,048,810,000.00 Net Margins-139.04% Return on Equity-54.86% Return on Assets-21.44%Miscellaneous Employees400 Outstanding Shares481,934,000Market Cap$1.30 billion Next Earnings Date11/13/2020 (Estimated) OptionableOptionable $2.69 +0.10 (+3.86 %) (As of 08/14/2020 04:00 PM ET) 30 days | 90 days | 365 days | Advanced Chart Receive CLNY News and Ratings via Email Sign-up to receive the latest news and ratings for CLNY and its competitors with MarketBeat's FREE daily newsletter. Colony Capital (NYSE:CLNY) Frequently Asked Questions How has Colony Capital's stock price been impacted by COVID-19 (Coronavirus)? Colony Capital's stock was trading at $2.97 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, CLNY stock has decreased by 9.4% and is now trading at $2.69. View which stocks have been most impacted by COVID-19. Do Wall Street analysts recommend investors buy shares of Colony Capital? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Colony Capital in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Colony Capital. When is Colony Capital's next earnings date? Colony Capital is scheduled to release its next quarterly earnings announcement on Friday, November 13th 2020. View our earnings forecast for Colony Capital. How were Colony Capital's earnings last quarter? Colony Capital Inc (NYSE:CLNY) posted its quarterly earnings results on Friday, May, 8th. The real estate investment trust reported ($0.76) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of $0.04 by $0.80. The real estate investment trust earned $32.87 million during the quarter, compared to the consensus estimate of $31.40 million. Colony Capital had a negative net margin of 139.04% and a negative return on equity of 54.86%. View Colony Capital's earnings history. How often does Colony Capital pay dividends? What is the dividend yield for Colony Capital? Colony Capital declared a quarterly dividend on Monday, March 2nd. Shareholders of record on Tuesday, March 31st will be given a dividend of $0.11 per share on Wednesday, April 15th. This represents a $0.44 dividend on an annualized basis and a dividend yield of 16.36%. The ex-dividend date of this dividend is Monday, March 30th. View Colony Capital's dividend history. What price target have analysts set for CLNY? 1 Wall Street analysts have issued twelve-month target prices for Colony Capital's stock. Their forecasts range from $4.00 to $4.00. On average, they expect Colony Capital's share price to reach $4.00 in the next year. This suggests a possible upside of 48.7% from the stock's current price. View analysts' price targets for Colony Capital. Has Colony Capital been receiving favorable news coverage? News stories about CLNY stock have been trending positive on Saturday, InfoTrie reports. InfoTrie identifies positive and negative press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Colony Capital earned a daily sentiment score of 2.4 on InfoTrie's scale. They also gave news headlines about the real estate investment trust a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the stock's share price in the next several days. View the latest news about Colony Capital. Are investors shorting Colony Capital? Colony Capital saw a increase in short interest in the month of June. As of June 15th, there was short interest totaling 12,370,000 shares, an increase of 54.8% from the May 31st total of 7,990,000 shares. Based on an average daily volume of 6,650,000 shares, the short-interest ratio is presently 1.9 days. Approximately 2.6% of the company's shares are short sold. View Colony Capital's Short Interest. Who are some of Colony Capital's key competitors? Some companies that are related to Colony Capital include ANNALY CAP MGMT/SH (NLY), AGNC Investment (AGNC), Starwood Property Trust (STWD), CHIMERA INVT CO/SH NEW (CIM), PennyMac Mortgage Investment Trust (PMT), Two Harbors Investment (TWO), Apollo Commercial Real Est. Finance (ARI), MFA FINL INC/SH (MFA), NY MTG TR INC/SH (NYMT), Redwood Trust (RWT), ARMOUR Residential REIT (ARR), CAPSTEAD MTG CO/SH (CMO), Invesco Mortgage Capital (IVR), Ready Capital (RC) and Dynex Capital (DX). View all competitors. What other stocks do shareholders of Colony Capital own? Based on aggregate information from My MarketBeat watchlists, some companies that other Colony Capital investors own include ANNALY CAP MGMT/SH (NLY), Energy Transfer LP Unit (ET), New Residential Investment (NRZ), AT&T (T), AGNC Investment (AGNC), Enterprise Products Partners (EPD), NGL Energy Partners (NGL), CHIMERA INVT CO/SH NEW (CIM), NY MTG TR INC/SH (NYMT) and Monroe Capital (MRCC). Who are Colony Capital's key executives? Colony Capital's management team includes the following people: Mr. Thomas Joseph Barrack Jr., Founder, Exec. Chairman & CEO (Age 70)Mr. Darren J. Tangen, Pres (Age 48)Mr. Kevin P. Traenkle, Exec. VP & Chief Investment Officer (Age 49)Mr. Mark Melvin Hedstrom CPA, Exec. VP, COO & CFO (Age 60)Mr. Neale W. Redington, MD & Chief Accounting Officer (Age 52) What is Colony Capital's stock symbol? Colony Capital trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLNY." Who are Colony Capital's major shareholders? Colony Capital's stock is owned by a variety of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (14.00%), Thompson Siegel & Walmsley LLC (1.96%), Goldman Sachs Group Inc. (1.71%), FMR LLC (1.54%), Bank of New York Mellon Corp (0.48%) and Prudential Financial Inc. (0.38%). Company insiders that own Colony Capital stock include Craig M Hatkoff, Dale Anne Reiss, Jacky Wu, Marc C Ganzi, Neale Redington, Raymond C Mikulich, Ronald M Sanders and Thomas Barrack Jr. View institutional ownership trends for Colony Capital. Which institutional investors are selling Colony Capital stock? CLNY stock was sold by a variety of institutional investors in the last quarter, including New York State Common Retirement Fund, Bank of New York Mellon Corp, Vanguard Group Inc., Prudential Financial Inc., State Board of Administration of Florida Retirement System, LSV Asset Management, Teachers Insurance & Annuity Association of America, and Strs Ohio. Company insiders that have sold Colony Capital company stock in the last year include Dale Anne Reiss, and Thomas Barrack Jr. View insider buying and selling activity for Colony Capital. Which institutional investors are buying Colony Capital stock? CLNY stock was acquired by a variety of institutional investors in the last quarter, including Goldman Sachs Group Inc., Canada Pension Plan Investment Board, Thompson Siegel & Walmsley LLC, American International Group Inc., SG Americas Securities LLC, Swiss National Bank, Stifel Financial Corp, and Sumitomo Mitsui Trust Holdings Inc.. Company insiders that have bought Colony Capital stock in the last two years include Craig M Hatkoff, Jacky Wu, Marc C Ganzi, Raymond C Mikulich, Ronald M Sanders, and Thomas Barrack Jr. View insider buying and selling activity for Colony Capital. How do I buy shares of Colony Capital? Shares of CLNY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Colony Capital's stock price today? One share of CLNY stock can currently be purchased for approximately $2.69. How big of a company is Colony Capital? Colony Capital has a market capitalization of $1.30 billion and generates $2.33 billion in revenue each year. The real estate investment trust earns $-1,048,810,000.00 in net income (profit) each year or $0.50 on an earnings per share basis. Colony Capital employs 400 workers across the globe. What is Colony Capital's official website? The official website for Colony Capital is www.clny.com. How can I contact Colony Capital? Colony Capital's mailing address is 515 SOUTH FLOWER STREET 44TH FLOOR, LOS ANGELES CA, 90071. The real estate investment trust can be reached via phone at 310-282-8820 or via email at [email protected] This page was last updated on 8/15/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
